NCT02188810View on ClinicalTrials.gov

Safety and Reactogenicity of a PAL Combined With Seasonal Flu Vaccine in Healthy Adults

PHASE1UnknownINTERVENTIONAL

Enrollment

48

Participants

Timeline

Start Date

April 30, 2014

Primary Completion Date

December 31, 2017

Study Completion Date

December 31, 2017

Conditions

Flu

Interventions

BIOLOGICAL

PAL

Single dose administered intramuscularly.

BIOLOGICAL

TIV

Single dose administered intramuscularly .

Trial Locations (1)

B3K 6R8

Canadian Center for Vaccinology, Halifax

Sponsors

Lead Sponsor

Folia Biotech Inc.

All Listed Sponsors

lead

Folia Biotech Inc.

INDUSTRY